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Salvage Surgery After Radiotherapy
for Laryngeal Cancer
From Endoscopic Resections to Open-Neck Partial and Total Laryngectomies
Cesare Piazza, MD; Giorgio Peretti, MD; Augusto Cattaneo, MD; Francesco Garrubba, MD;
Luca Oscar Redaelli De Zinis, MD; Piero Nicolai, MD
Objective: To evaluate our experience in management
of radiotherapy failure using endoscopic resection (ER)
with carbon dioxide laser, open-neck partial laryngec-
tomy (ONPL), and total laryngectomy.
Design: Retrospective medical record review.
Setting: Referral university hospital.
Patients: Seventy-one patients with laryngeal cancer
previously treated with radiotherapy (69 patients) and
chemoradiotherapy (2 patients) underwent salvage
surgery.
Interventions: The treatment policy encompassed ER
for glottic rT1a, rT1b with limited anterior commissure
involvement, and rT2 with normal cord mobility carci-
noma. All ONPLs were performed for rT1 and rT2 tu-
mors with suboptimal endoscopic exposure, rT2 tu-
mors with impaired cord mobility or transcommissural
extension, and rT3 tumors for limited paraglottic space
invasion or involvement of the inner portion of the thy-
roid cartilage. Total laryngectomy was planned in pa-
tients who were not suitable for partial laryngectomy
owing to poor general condition, for rT3 carcinomawith
massive involvement of the paraglottic space, and for rT4a
tumors.
Main Outcome Measures: Clinical, radiologic, sur-
gical, and pathologic data. Survival curves were calcu-
lated using the Kaplan-Meier method. Comparisons
between different variables were performed using the
log-rank test.
Results: Salvage surgery consisted of ER in 22 patients,
ONPL in 15, and total laryngectomy in 34. The pT cat-
egory after salvage surgery was pT1 in 12 patients, pT2
in 20, pT3 in 20, and pT4a in 19. Five-year disease-
specific and disease-free survival and laryngeal preser-
vation for the entire series were 72%, 61%, and 40%,
respectively.
Conclusions: Survival rates for the entire series were not
different from those previously reported using amore ag-
gressive surgical approachwithout attempts at organ pres-
ervation. The laryngeal preservation rate justifies con-
servative treatment in the presence of limited recurrent
lesions.
ArchOtolaryngolHeadNeckSurg.2007;133(10):1037-1043
R ADIOTHERAPY AND, MORErecently, organ preserva-tion protocols using con-comitant chemoradio-therapy are becoming the
most common first-line treatments for
many patients with laryngeal cancer. Al-
though 5-year local control rates for ra-
diotherapy in T1 and T2 laryngeal carci-
noma range from 67% to 93% and
progressively declinewith increasingT cat-
egory, recurrence rates of 21% to 37% for
T1 and T2 glottic lesions and 30% to 45%
for T1 and T2 supraglottic lesions are fre-
quently reported even in large series.1-3 In
many centers, total laryngectomy (TL) is
still considered the safest and easiest sal-
vage option after radiotherapy failure even
though it sacrifices the voice, requires a
permanent stoma, and is frequently asso-
ciated with serious perioperative compli-
cations. Such a treatment strategy is only
in part justified by the frequently ob-
served progression of initially staged T1
and T2 tumors toward more extensive le-
sions, by an understandable tendency to
more aggressively treat recurrences, and
by objective difficulties in correctly re-
staging the tumor in patientswhohave pre-
viously undergone irradiation.
A variety of studies4-21 addressing the
results of different conservative options af-
ter radiotherapy failure for selected pa-
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tients with a disease control at least comparable with that
obtained with TL have been published: they encompass
endoscopic resection (ER) with carbon dioxide la-
ser4,22-28 and different types of open-neck partial laryn-
gectomy (ONPL). Comparisons between different selec-
tion criteria, oncologic and functional outcomes, and
complication rates for each surgical approach are pos-
sible, as detailed in the recent review byMotamed et al.29
However, biases deriving fromnonhomogeneous recruit-
mentmodalities, differences in radiation and surgical tech-
niques, and various follow-up modalities are unavoid-
able when comparing series from different institutions.
To our knowledge, this is the second study, after that
recently published by Holsinger et al30 from the M. D.
Anderson Cancer Center, that comprehensively ad-
dresses all available salvage surgical options (ER, ONPL,
and TL with or without flaps) applied at the same insti-
tution and based on a homogeneous, retrospective se-
ries of unselected patients. This allows direct compari-
sons in terms of indications, oncologic outcomes, and
complication rates among the different surgical
approaches.
METHODS
Between January 17, 1995, and March 23, 2004, 71 patients
(male to female ratio, 68:3; mean age, 63.4 years; age range,
45-86 years) with laryngeal squamous cell carcinoma previ-
ously treated with radiotherapy (69 patients) and chemoradio-
therapy (2 patients) were treated at the Department of Otorhi-
nolaryngology, University of Brescia, by 1 of the 5 senior
surgeons, or under their direct supervision, sharing a com-
mon therapeutic strategy. Salvage surgerywas indicated for per-
sistence (tumor in the same or adjacent sites of the primary le-
sion detected 6 months after the completion of nonsurgical
treatment) in 11 patients, recurrence (tumor diagnosed 6-60
months after the end of treatment) in 50 patients, or second
laryngeal tumor (neoplasm arising60months after manage-
ment of the first tumor) in 10 patients.
Medical record review was performed to obtain clinical, ra-
diologic, surgical, and pathologic data. Preradiotherapy stag-
ingwas retrospectively reassessed according to the 2002 Ameri-
can Joint Committee onCancer TNM staging system (Table1).
All the patients received radiotherapy using cobalt 60, with a
mean dose of 68Gy (to convert to rad, multiply by 100) (range,
64-72 Gy), delivered daily as 2 Gy for 5 days per week. Pa-
tients with T1 lesions received narrow-field radiation to the pri-
mary site, and patients with higher T categories also received
radiotherapy to nodal groups II to IV. Concomitant chemora-
diotherapywas administered to 2 patients affected by a T3 trans-
glottic tumor and consisted of fluorouracil, 1000mg/m2 per day,
and cisplatin, 20 mg/m2 per day, both given as continuous in-
travenous infusions for 4 days beginning on the first and fourth
weeks of radiotherapy. The mean disease-free interval be-
tween the end of nonsurgical organ preservation treatment and
the diagnosis of recurrence, persistence, or a second laryngeal
tumor for the entire serieswas 19months (range, 3-113months).
All the patients were preoperatively examined by means of
fiberoptic laryngoscopy, videolaryngostroboscopy, and com-
puted tomography ormagnetic resonance imaging to assess the
superficial and deep extension of the lesion in the visceral com-
partments and to exclude or quantify involvement of the la-
ryngeal framework. Ultrasonography of the neck with or with-
out fine-needle aspiration cytologic examinationwas performed
in selected patients with clinically evident neck metastases or
tumors with a high risk of occult nodal disease. Moreover, all
the patients underwentmicrolaryngoscopic examination using
0° and angled rigid endoscopes (Karl Storz, Tuttlingen, Ger-
many) to improve clinical and radiologic staging of the lesion.
Accordingly, we obtained preoperative staging of these pa-
tients as reported in Table 1. After accurate restaging of the re-
current lesion and comprehensive evaluation of the patient’s
general condition, every case was thoroughly discussed in a col-
legial form during preoperative counseling to clearly explain
the different therapeutic options (if available) along with their
advantages and disadvantages to the patient.
The treatment policy encompassed ER for glottic rT1a tu-
mors, rT1b tumors with limited anterior commissure involve-
ment, and rT2 tumors with normal cord mobility. An essen-
tial prerequisite for this approach was adequate laryngeal
exposure as determined during the initial microlaryngoscopic
examination. The ER was performed using a carbon dioxide
laser (Sharplan 1055 S) coupled with a micromanipulator
(AcuSpot 712) (Sharplan, Tel Aviv, Israel)with superpulse emis-
sion in continuous mode (2.5-5.0 W, 270-µm spot size). The
procedures were categorized according to the European Lar-
yngological Society classification.32 No patient in this group re-
ceived either a tracheotomy or a feeding tube. Oral feeding al-
ways began the day after surgery.
The ONPLs were performed for rT1 and rT2 lesions with
suboptimal endoscopic exposure, rT2 lesionswith impaired cord
mobility or transcommissural extension, and rT3 lesions for
limited paraglottic space invasion or involvement of the inner
portion of the thyroid cartilage. Paraglottic space invasion and
erosion of the inner portion of the thyroid cartilage were pre-
operatively evaluated by means of radiologic imaging. In par-
ticular, minimal paraglottic space involvement was defined as
that observed in patients with rT2 glottic tumors with normal
or reduced vocal cord mobility in which the fat tissue lateral
to the vocal muscle was partially encroached on by the neo-
plasmbut not completely replaced by the tumor.Moreover, can-
didacy for conservation laryngeal surgery was evaluated pre-
operatively in all patients by using pulmonary function tests
and cardiologic examination to assess the adequacy of pa-
tients’ general condition. The types of ONPL performed in-
cluded horizontal supraglottic laryngectomy and supracricoid
partial laryngectomy (SCPL) with cricohyoidoepiglottopexy,
with cricohyoidopexy, and with tracheocricohyoidoepiglot-
topexy. All patients underwent intraoperative tracheotomy at
the fourth to sixth tracheal ring, with an inferiorly based tra-
cheal flap and a feeding tube. When patients could breathe
through the natural airway, the tracheotomy tube was plugged
and definitively removed after 48 hours of effortless breath-
ing. Swallowing rehabilitation usually began 10 to 12 days af-
Table 1. Preradiotherapy, Clinical, and Pathologic T
Categories of the Laryngeal Tumors in the 71 Patients
in the Present Series
T Categorya
Patients, No. (%)
Preradiotherapy
Staging
Recurrence Staging
Clinical Pathologic
T1a 28 (40) 10 (14) 10 (14)
T1b 5 (7) 7 (10) 2 (3)
T2 15 (21) 29 (41) 20 (28)
T3 15 (21) 18 (25) 20 (28)
T4a 8 (11) 7 (10) 19 (27)
aAccording to the most recent edition of the American Joint Committee on
Cancer TNM staging system.31
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ter surgery, beginning with soft foods. Voice rehabilitation be-
gan 2 to 3 days after surgery to avoid ankylosis of the
cricoarytenoid joint.
Total laryngectomyas first-line salvage treatmentwas planned
in patientswhowere not suitable forONPLs owing to poor over-
all health status and locoregional conditions (massive laryn-
geal edema, suggestion of chondronecrosis, and diffuse fibro-
sis of the neck), for rT3 tumors with massive involvement of
the paraglottic space (tumors with complete fixation of the vo-
cal cord orwith radiologic evidence of complete neoplastic oblit-
eration of the fat-filled space located lateral to the vocalmuscle),
and for rT4a cancers. Primary flaps were used either as an ex-
ternal covering of a regular neopharyngeal suture or as a patch
in case of insufficient pharyngeal tissue, whereas secondary flaps
were applied to close pharyngocutaneous fistulas that were not
responsive to standard conservative treatment. A nasogastric
feeding tubewas always positioned during surgery andwas usu-
ally removed 12 days after surgery in the absence of overt clini-
cal signs of fistula or a negative barium swallow test result. Patho-
logic staging after salvage surgery in patients included in groups
A, B, and C is reported in Table 1.
All patients treated by ER (group A) had a clinically normal
neck according to results of palpation, ultrasonography, and com-
puted tomography and therefore did not undergo neck dissec-
tion. In contrast, 8 of 15 patients (53%) treated byONPLs (group
B) and all patients undergoing TL (group C) were concomi-
tantly treated with unilateral or bilateral neck dissection.
All patients received postoperative prophylactic antibiotic
drug therapy for at least 8 days, even when scheduled for ER,
to reduce the possibility of postoperative chondritis and chon-
dronecrosis. In the case of ONPLs, antibiotic agents were given
for the duration of swallowing rehabilitation to prevent aspi-
ration pneumonia, whereas in patients undergoing TL, antibi-
otic drug therapy was usually discontinued after feeding tube
removal in the absence of clinically evident salivary fistulas. The
most frequently used antibiotics were ampicillin sodium plus
sulbactam sodium (1.5 g intravenously 3 times daily), associ-
ated with ciprofloxacin (200mg intravenously twice daily) and
metronidazole phosphate (500mg intravenously 3 times daily)
only in the case of pulmonary or locoregional complications.
Follow-up visits included fiberoptic examination every 2
months, computed tomography of the larynx every 12months,
and, when indicated, ultrasonography of the neck every 6
months. The last follow-up was in March 2006 (mean follow-
up, 46months; range, 6-121months), and5-year overall, disease-
specific, and disease-free survival and laryngeal preservation
rates were calculated using the Kaplan-Meier method for the
entire series and for each group of patients. Comparisons of
different variables using the log-rank test were performed. Sta-
tistical analysis was performed using a commercially available
computer software package (SPSS; SPSS Inc, Chicago, Illinois).
RESULTS
GroupAwas composed of 22 patients (31%) treatedwith
ER, including 9 transmuscular (type III) cordectomies
(for glottic rT1a tumors), 4 total (type IV) cordectomies
(for glottic rT2 tumors with impaired cordmobility), and
9 extended (type V) cordectomies (further subgrouped
into 5 type Va cordectomies [ie, extended to the ante-
rior commissure and contralateral vocal cord for rT1b
tumors involving both vocal cords] and 4 type Vc cor-
dectomies [ie, extended to the bottom and roof of the ven-
tricle, including the false vocal fold for glottic-
supraglottic rT2 tumors with normal cord mobility and
without radiologic evidence of paraglottic space inva-
sion]). The preradiotherapy, clinical (before salvage sur-
gery), and pathologic (after salvage surgery) T catego-
ries are reported in Table2. Hospitalization ranged from
3 to 9 days (mean, 4 days). Early complications (within
1 month of surgery) were not encountered. Three pa-
tients (14%) experienced late thyroid cartilage chondri-
tis (1 patient) or chondronecrosis (2 patients), whichwere
all successfully treated with hyperbaric oxygen therapy.
At the last follow-up visit, 14 patients were alive andwell
(despite TL in 1 patient initially staged as having rT1b
carcinoma and further ERs in 3 patients, 1 initially staged
as rT1a and 2 as rT2), 1 patient treated for an rT1a tu-
mor was alive with disease at the stomal site after an-
other recurrence requiring TL, 1 patient with an rT2 le-
sion died of laryngeal cancer despite TL for a subsequent
recurrence, and 6 patients died of other causes (myocar-
dial infarction in 2, stroke in 2, hepatocarcinoma after
TL for further recurrence in a previously rT2 lesion in
1, and renal failure in 1). Of the 7 patients with recur-
rence after salvage laser surgery, 1 had anterior commis-
sure involvement (rT1b) when first seen after radio-
therapy, and 4 had rT2 lesions (2 with anterior
commissure extension). Kaplan-Meier curves for group
A showed5-year disease-specific survival, disease-free sur-
vival, and laryngeal preservation of 95%, 63%, and 75%,
respectively (Figures 1, 2, and 3).
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Figure 1. Five-year disease-specific survival for group A (endoscopic
resection [ER]), group B (open-neck partial laryngectomy [ONPL]), and
group C (total laryngectomy [TL]) according to the Kaplan-Meier method.
Table 2. Preradiotherapy, Clinical, and Pathologic T
Categories of the 22 Patients in Group A
T Categorya
Patients, No.
Preradiotherapy
Staging
Recurrence Staging
Clinical Pathologic
T1a 16 9 9
T1b 2 5 2
T2 2 8 11
T3 2 0 0
T4a 0 0 0
aAccording to the most recent edition of the American Joint Committee on
Cancer TNM staging system.31
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Group B consisted of 15 patients (21%) treated by
ONPLs distributed as follows: horizontal supraglottic lar-
yngectomy (1 patient with an rT2 supraglottic tumor)
and SCPL with cricohyoidoepiglottopexy (9 patients:
1 with a glottic rT1a tumor, 1 with a glottic rT1b tumor,
and 7 with a glottic rT2 tumor with impaired cord mo-
bility), cricohyoidopexy (4 patients with glottic-
supraglottic rT2 lesions), and tracheocricohyoidoepi-
glottopexy (1 patientwith a glottic-subglottic rT2 tumor).
The preradiotherapy, clinical, and pathologic T catego-
ries are reported in Table3. Hospitalization ranged from
16 to 50 days (mean, 30 days). Decannulation was
achieved in all patients, with intervals from surgery rang-
ing from 10 to 120 days (mean, 41 days). Removal of the
feeding tube was also accomplished in all patients, with
an interval of 14 to 120 days (mean, 38 days). Early com-
plications were observed in 6 patients (40%) and con-
sisted of 1 pharyngocutaneous fistula withmassive bleed-
ing requiring TL and internal jugular vein ligation, 2 cases
of aspiration pneumonia at the beginning of swallowing
rehabilitation (in 1 case requiring percutaneous endo-
scopic gastrostomy, removed 50 days later), 2 partial de-
hiscences of the pexy (healed after hyperbaric oxygen
therapy), and 1 limited dehiscence of the cervical wound
(healed by second intention). Late complications (in par-
ticular, aspiration pneumonia) were not encountered. At
the last follow-up visit, 13 patients were alive and well
(despite 2 TLs, in 1 patient for perioperative complica-
tions and in another for a second recurrence on the re-
sidual larynx in an rT3 tumor), 1 was alive with re-
gional disease after TL and neck dissection in an initially
staged rT2 lesion, and 1 had died of a stroke. Kaplan-
Meier curves for this group showed 5-year disease-
specific survival, disease-free survival, and laryngeal pres-
ervation of 100%, 83%, and 83%, respectively (Figures 1,
2, and 3).
Group C included 34 patients (48%) treated with TL
(1 with a glottic rT1b tumor with intraoperative evi-
dence of thyroid cartilage invasion, 8 with rT2 lesions
with impaired vocal cordmobility or supraglottic and glot-
tic extension, 18 with glottic rT3 tumors with vocal cord
fixation, and 7 with rT4a lesions with thyroid or cricoid
cartilage invasion or hypopharyngeal involvement). In
6 patients (18%), we coupled TL with a primary (2 pa-
tients) or secondary (4 patients) pedicled (myocutane-
ous or myofascial major pectoralis) or free (radial fore-
arm) flap. The preradiotherapy, clinical, and pathologic
T categories are reported in Table 4. Hospitalization
ranged from 15 to 45 days (mean, 25 days). Removal of
the feeding tube was accomplished between 12 and 50
days (mean, 22 days). Early complications were ob-
served in 13 patients (38%) and were mainly repre-
sented by pharyngocutaneous fistula (12 patients). This
Table 4. Preradiotherapy, Clinical, and Pathologic T
Categories of the 34 Patients in Group C
T Categorya
Patients, No.
Preradiotherapy
Staging
Recurrence Staging
Clinical Pathologic
T1a 5 0 0
T1b 3 1 0
T2 6 8 3
T3 12 18 12
T4a 8 7 19
aAccording to the most recent edition of the American Joint Committee on
Cancer TNM staging system.31
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Figure 2. Five-year disease-free survival for group A (endoscopic resection
[ER]), group B (open-neck partial laryngectomy [ONPL]), and group C (total
laryngectomy [TL]) according to the Kaplan-Meier method.
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Figure 3. Five-year laryngeal preservation rates for group A (endoscopic
resection [ER]) and group B (open-neck partial laryngectomy [ONPL])
according to the Kaplan-Meier method.
Table 3. Preradiotherapy, Clinical, and Pathologic T
Categories of the 15 Patients in Group B
T Categorya
Patients, No.
Preradiotherapy
Staging
Recurrence Staging
Clinical Pathologic
T1a 7 1 1
T1b 0 1 0
T2 7 13 6
T3 1 0 8
T4a 0 0 0
aAccording to the most recent edition of the American Joint Committee on
Cancer TNM staging system.31
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was conservatively managed in 7 patients by compres-
sive bandages twice daily, whereas 1 patient required lo-
cal revision with primary sutures and 4 needed second-
arymyofascial ormyocutaneous pedicled pectoralismajor
flaps. In 2 patients receiving primary reconstructionwith
radial forearm free flaps at the end of salvage surgery, no
fistulizationwas observed. One case of postoperative chy-
lous leak was also encountered and conservatively man-
aged by compressive bandages on the left supraclavicu-
lar region. No late complication was diagnosed in this
group of patients. At the last follow-up visit, 14 patients
were alive and well, 14 had died of locoregional recur-
rence or distantmetastasis, and 6 had died of other causes
(2 lung tumors, 1 hepatocarcinoma, 2 acute myocardial
infarctions, and 1 stroke). Kaplan-Meier curves for this
group showed 5-year disease-specific and disease-free sur-
vival of 48% and 51%, respectively (Figures 1 and 2). One
of 8 patients (13%) treated with neck dissection in group
B was N (pN1). Eight of 34 patients (24%) who un-
derwent this procedure in groupCwereN (2were pN1,
4 were pN2b, 1 was pN2c, and 1 was pN3).
The complication rate for the entire series was 31%,
with 5-year overall survival, disease-specific survival, dis-
ease-free survival, and laryngeal preservation of 54%, 72%,
61%, and40%, respectively. Comparison of 5-year disease-
specific survival in groups A, B, and C showed a signifi-
cant difference (P .001). A similar result was observed
when comparing 5-year disease-specific survival on the
basis of the preradiotherapy, clinical (before salvage sur-
gery), and pathologic T categories (P=.03, P .001, and
P .001, respectively). In contrast, no significant differ-
ence was observed when comparing 5-year disease-free
survival in groups A, B, and C (P=.20). There were no
significant differences in the laryngeal preservation rates
of groups A and B (P=.5).
COMMENT
Before treating laryngeal cancer recurrent after radio-
therapy failure, a variety of factors should be evaluated
to choose the most appropriate treatment. The first and
essential element is the preradiotherapy staging of the le-
sion, which must be accurately compared with that of
the recurrent lesion. In fact, 6.5% to 30.0% of recur-
rences of early laryngeal cancers tend to be localized,33
and although tumor margins may vary after radio-
therapy and their identification during endoscopic and
open-neck surgery can be difficult even for the experi-
enced surgeon, a definite role for conservative ap-
proaches has already been demonstrated.29,30 The choice
betweenERusing carbon dioxide laser andONPLs should
be based on the extension and characteristics of the tu-
mor, overall health status, and the possibility to obtain
complete laryngeal exposure for endoscopic purposes.
However, a highly variable spectrum of indications for
ER related to tumor extent have been reported.4,22-28 The
present selection criteria are strict and rather limited com-
pared with those of other investigators,23,24,28 who in-
cluded rT3 and rT4 lesions with extensive involvement
of the anterior commissure in their endoscopic series. Al-
though involvement of the anterior commissure does not
represent a contraindication for ER of previously un-
treated glottic tumors,34 extreme caution should be used,
in our experience,27 for rescue ER of such lesions after
radiotherapy failure in view of the normal appearance,
evenunder endoscopicmagnification, of the anterior com-
missure mucosa (marginally involved in 3 of the 7 re-
currences in this series), which can hide the persistence
of deep nests of tumor invading visceral compartments
or focally involving the laryngeal framework.35,36 In the
case of macroscopic involvement of the anterior com-
missure by recurrent tumors, we prefer to perform SCPLs,
which present wider safe margins of resection and avoid
the risk of thyroid cartilage chondronecrosis, one of the
most feared complications of vertical partial laryngecto-
mies after radiotherapy failure.20,37
The most appealing features of ER are the possibility
to make a tumor-tailored excision without any recon-
structive limitations in terms of tension of the pexy or
symmetry, to precisely stage the lesion with a micro-
scope, possibly switching to an ONPL whenever the tu-
mor is beyond the presumed preoperative limits. Shorter
hospitalizations, lower complication rates, better func-
tional outcomes in terms of voice and swallowing, and a
more favorable cost-effectiveness ratio are other advan-
tages of this treatmentmodality, as demonstrated by other
series.4,22-28 Five-year disease-free survival and laryngeal
preservation rates obtained with ER in rT1 and rT2 car-
cinoma are certainly lower than those observed in pri-
mary ER.34 Nonetheless, the 5-year disease-specific sur-
vival of 95%emphasizes the importance of strict follow-up
with regular fiberoptic examinations andperiodic imaging,
allowing early detection and treatment of further recur-
rences without a negative impact on survival.26,27 More-
over, the difference between the laryngeal preservation
rates in groups A and B (75% and 83%, respectively) was
not statistically significant.
In this experience, ONPLs mainly included all vari-
ants of SCPL. Horizontal supraglottic laryngectomy was
used in only 1 patient according to the general opinion
that the procedure has limited value as salvage surgery
after radiotherapy.5,19,29 Most of the recurrences extend-
ing to the supraglottis were treated using SCPL with cri-
cohyoidopexy. The SCPLs allow a wide tumor resection
while preserving aerodigestive continuity and a lung-
powered voice.Moreover, the possibility of obtaining com-
plete clearance of the entire paraglottic space ipsilateral
to a sacrificed arytenoid and, in the case of SCPL with
cricohyoidopexy, of the entire preepiglottic space ex-
pands the indications of this technique to include glot-
tic T2 tumors with impaired vocal cord mobility, T3 tu-
mors with limited paraglottic space invasion, and
supraglottic T3 tumors with pre-epiglottic involve-
ment. Although some rT3 lesions were included in group
B, SCPLs showed 5-year disease-free and disease-spe-
cific survival comparable with or even superior to those
reported in most postradiation vertical partial laryngec-
tomies series.5,6,8,10,11,13,14,17,19 This was achieved with an
increase in perioperative morbidity that was not differ-
ent from that observed after salvage TL.
The potentially higher morbidity rate for SCPLs, al-
readymentioned by several researchers,12,18 was encoun-
tered even in the present series, but it did not statisti-
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cally significantly affect the overall laryngeal preservation
rate. However, patient selection before SCPLs, in rela-
tion to the precise tumor extension and adherence to a
lengthy rehabilitation trial, likely remains the most dif-
ficult and subjective argument and must be resolved on
a case-by-case basis. Beyond pulmonary and cardiologic
functions, subtle elements such as dexterity, compli-
ance, self-motivation, and support from the surround-
ing social environment must be adequately assessed to
properly choose the candidates for such a procedure.12
More than half of the patients in this series could ini-
tially retain their larynx after undergoing ER or ONPL.
This percentage decreased to 40% in the subsequent
5 years, mainly for further local recurrences or, less
frequently, for surgery-related complications. This is
of paramount importance when considering that all
these patients would have obtained similar local con-
trol of disease (reported to be 60% to 80% for rT1-rT2
tumors after salvage TL and 50% for advanced T cat-
egory tumors)1,7,38 with comparable perioperative mor-
bidity but without any organ preservation in the case
of TL alone.
In the present series, as in others,33 approximately half
of the patients had locally advanced disease at the time
of detection. In addition, medical comorbidities and so-
cioeconomic constraints inmany cases prevented the ap-
plication of larynx-preserving procedures. The 5-year dis-
ease-specific and disease-free survival rates of TL in this
cohort likely reflect the negative prognostic effect of the
most locally advanced tumors that were not deemed can-
didates for conservation procedures. Even the compli-
cation rates were not negligible, although they are simi-
lar to those reported previously,33,39,40 and were mainly
related to pharyngocutaneous fistulas. An extensive and
prophylactic use of pedicled or free flaps in these pa-
tients seems to help in preventing or reducing the inci-
dence and severity of fistulas.40 The only 2 patients in
whom we chose to adopt such a policy for poor tissue
condition (edematous and pale hypopharyngeal mu-
cosa requiring removal of part of the piriform sinuses)
regained a normal oral diet without developing fistulas.
In contrast, most flaps harvested by us for purely laryn-
geal cancer recurrent after radiotherapy were for second-
ary closure of fistulas clinically progressing despite con-
servative methods.
In conclusion, these proposed selection criteria strictly
stratify instances of laryngeal radiotherapy failure into
different groups amenable to various types of conserva-
tive surgery or TL on the basis of well-known tumor- and
patient-related variables. This treatment policy allowed
us to spare the larynx initially in more than half of the
individuals whowere candidates for salvage surgery. This
percentage progressively reduced in the following 5 years
to 40%, still maintaining survival rates comparable with
those commonly reported for more aggressive ap-
proaches, without any attempt at organ preservation.
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